Who owns SILENCE THERAPEUTICS PLC?

Tip: Access positions for across all investors

Analyze quarterly positions in Silence Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Silence Therapeutics stock

Who bought or sold SILENCE THERAPEUTICS PLC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
TCG Crossover Management 3.3M $63M 0% Jun 2024
 View chart
Artal Group 2.8M $53M 0% Jun 2024
 View chart
Redmile Group 2.0M $38M -1% Jun 2024
 View chart
Logos Global Management 1.5M $28M 0% Jun 2024
 View chart
Deep Track Capital 1.4M $26M -17% Jun 2024
 View chart
Frazier Life Sciences Management 1.1M $22M 0% Jun 2024
 View chart
Nextech Invest 952k $18M 0% Jun 2024
 View chart
Henderson Group 819k $16M 31% Jun 2024
 View chart
Millennium Management 783k $15M 91% Jun 2024
 View chart
Cormorant Asset Management 625k $12M 0% Jun 2024
 View chart
Ikarian Capital 507k $3.3M 100% Jun 2024
 View chart
Aquilo Capital Management 500k $9.5M -13% Jun 2024
 View chart
5AM Venture Management 476k $9.0M 0% Jun 2024
 View chart
Duquesne Family Office 387k $7.4M 0% Jun 2024
 View chart
SG Americas Securities 343k $6.2M 0% Sep 2024
 View chart
Morgan Stanley 304k $5.8M 25% Jun 2024
 View chart
Parkman Healthcare Partners 290k $5.5M 19% Jun 2024
 View chart
Cantor Fitzgerald, L. P. 248k $4.7M 140% Jun 2024
 View chart
Hudson Bay Capital Management 208k $4.0M -25% Jun 2024
 View chart
Nantahala Capital Management 200k $3.8M 0% Jun 2024
 View chart
M28 Capital Management 185k $3.5M -38% Jun 2024
 View chart
Hsbc Holdings 178k $3.4M 0% Jun 2024
 View chart
Octagon Capital Advisors 176k $3.3M -44% Jun 2024
 View chart
Marshall Wace 149k $2.8M 7% Jun 2024
 View chart
Point72 Asset Management 147k $2.8M 1687% Jun 2024
 View chart
Stempoint Capital 125k $2.4M 100% Jun 2024
 View chart
Citadel Advisors 117k $2.2M 174% Jun 2024
 View chart
Two Sigma Investments 99k $1.9M -8% Jun 2024
 View chart
Woodline Partners 91k $1.7M -62% Jun 2024
 View chart
Two Sigma Advisers 76k $1.4M -2% Jun 2024
 View chart
Schonfeld Strategic Advisors 75k $1.4M -44% Jun 2024
 View chart
Citigroup 58k $1.1M 0% Jun 2024
 View chart
Artia Global Partners 53k $997k 0% Jun 2024
 View chart
Renaissance Technologies 39k $743k -62% Jun 2024
 View chart
TD Asset Management 31k $559k 100% Sep 2024
 View chart
Geode Capital Management 29k $559k 31% Jun 2024
 View chart
William Blair $ Company 25k $483k 0% Jun 2024
 View chart
Trexquant Investment 22k $414k 4% Jun 2024
 View chart
Legato Capital Management 20k $376k 100% Jun 2024
 View chart
Rathbones Brothers 18k $350k -7% Jun 2024
 View chart
Y-Intercept 17k $326k 100% Jun 2024
 View chart
Goldman Sachs Group 16k $309k -25% Jun 2024
 View chart
Custom Index Systems 14k $262k -3% Sep 2024
 View chart
Jump Financial 12k $235k -34% Jun 2024
 View chart
Bank of America Corporation 10k $190k -17% Jun 2024
 View chart
Cubist Systematic Strategies 9.4k $179k -74% Jun 2024
 View chart
Quarry 6.0k $114k 100% Jun 2024
 View chart
Barclays 5.6k $105k 0% Jun 2024
 View chart
Royal Bank of Canada 4.7k $89k 100% Jun 2024
 View chart
Values First Advisors 3.1k $56k 100% Sep 2024
 View chart
GAMMA Investing 859.00 $16k 0% Sep 2024
 View chart
Rhumbline Advisers 469.00 $8.9k 3027% Jun 2024
 View chart
Steward Partners Investment Advisory 100.00 $1.9k 0% Jun 2024
 View chart
Lazard Asset Management 60.00 $1.0k -96% Jun 2024
 View chart

Who sold out of Silence Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Lynx1 Capital Management Mar 2024 527k $11M
New York State Common Retirement Fund Jun 2024 24k $457k
Shay Capital Mar 2024 15k $327k
Jpmorgan Chase & Co Mar 2024 9.6k $208k
Advisors Preferred Jun 2024 5.3k $100k
Qube Research & Technologies Mar 2024 3.9k $85k